Virtus ETF Advisers
ADMA icon

Virtus ETF Advisers’s ADMA Biologics ADMA Stock Holding History

Virtus ETF Advisers’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$231K Buy
23,020
+4,608
+25% +$42.6K 0.08% 274
2026
Q2 		$154K Hold
18,412
– – 0.06% 318
2026
Q1 		$166K Hold
18,412
– – 0.08% 269
2025
Q4 		$336K Hold
18,412
– – 0.16% 158
2025
Q3 		$270K Hold
18,412
– – 0.15% 178
2025
Q2 		$335K Hold
18,412
– – 0.2% 135
2025
Q1 		$365K Sell
18,412
-316
-2% -$5.46K 0.24% 128
2024
Q4 		$321K Sell
18,728
-11,824
-39% -$222K 0.13% 236
2024
Q3 		$611K Hold
30,552
– – 0.29% 177
2024
Q2 		$342K Sell
30,552
-63,760
-68% -$535K 0.17% 202
2024
Q1 		$622K Buy
94,312
+13,569
+17% +$74.2K 0.33% 155
2023
Q4 		$365K Buy
80,743
+2,519
+3% +$9.32K 0.23% 180
2023
Q3 		$280K Sell
78,224
-10,111
-11% -$38.9K 0.17% 208
2023
Q2 		$326K Buy
88,335
+4,410
+5% +$16.3K 0.19% 180
2023
Q1 		$278K Buy
83,925
+1,486
+2% +$5.14K 0.15% 256
2022
Q4 		$320K Buy
+82,439
New +$254K 0.17% 240

Other funds holding ADMA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Virtus ETF Advisers's ADMA Position: Q3 2026 in Review

Virtus ETF Advisers increased its ADMA Biologics (ADMA) stake by 25% in Q3 2026, buying an estimated $42.6K and bringing the position to 23,020 shares worth $231K. The position accounts for 0.08% of the portfolio, ranked #274.

Virtus ETF Advisers first reported a position in ADMA in Q4 2022 and has held it in 16 quarters since. The position peaked at $622K in Q1 2024. 262 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Virtus ETF Advisers held 23,020 shares of ADMA Biologics worth $231K as of Q3 2026.
  • Virtus ETF Advisers bought 4,608 ADMA Biologics shares in Q3 2026, an estimated $42.6K.
  • ADMA Biologics made up 0.08% of Virtus ETF Advisers's portfolio in Q3 2026, its #274 holding.
  • Virtus ETF Advisers first reported a position in ADMA Biologics in Q4 2022 and has held it in 16 quarters since.
  • Virtus ETF Advisers's ADMA Biologics position peaked at $622K in Q1 2024.
  • 262 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.